In addition, through a molecular pathway similar to that in the AD cell model, VPA and WT161 also substantially reduced the number and size of Aβ amyloid plaques in the cerebral cortex and hippocampus of APP/PSEN1 mice (Figs. 9 and 10). This evidence concerns the gene APP and Alzheimer disease.